Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma

OBJECTIVE: To evaluate the performance of the nuclear matrix protein 22 (NMP22) BladderChek test in urothelial carcinoma (UC). METHODS: We retrospectively analyzed 1318 patients who performed the NMP22 BladderChek tests. Of them, 103 were primary UC patients, 90 were surgical treatment UC patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Chang-sheng, Fan, Chun-hong, Su, Ming, Wang, Qing-song, Bao, Hui-zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232672/
https://www.ncbi.nlm.nih.gov/pubmed/32454904
http://dx.doi.org/10.1155/2020/3424039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232672/
https://www.ncbi.nlm.nih.gov/pubmed/32454904
http://dx.doi.org/10.1155/2020/3424039

Ejemplares similares